Impact of rehabilitation unit-based physical activity therapy versus symptomatic supportive treatment on older patients with advanced cancer: a non-randomized controlled study

被引:0
|
作者
Lu, Xiaoqiong [1 ]
Wei, Shubao [1 ]
Liang, Benzi [1 ]
Huang, Cheng [1 ]
Meng, Weiwei [1 ]
Zhang, Xiaojing [1 ]
Chen, Xiuqiong [1 ]
机构
[1] Jiangbin Hosp Guangxi Zhuang Autonomous Reg, Dept Pain Rehabil, 85 Hedi Rd, Nanning 530000, Guangxi, Peoples R China
关键词
Advanced cancer; Older patients; Physical activity therapy; Rehabilitation; QUALITY-OF-LIFE; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; EXERCISE GUIDELINES; EORTC QLQ-C30; USUAL CARE; FATIGUE; QUESTIONNAIRE; METAANALYSIS;
D O I
10.1007/s00520-024-08701-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Relatively few studies have investigated the effects of rehabilitation-based physical activity therapy as a treatment for older patients with advanced cancer. This study evaluated the effects of individualized precise and structured exercise interventions, prescribed by a rehabilitation physician, on fatigue, quality of life (QOL), and physical activity in older patients with advanced cancer. Methods: After admission to the rehabilitation department, older cancer patients were divided into groups receiving conventional symptomatic supportive therapy (SST) or physical activity therapy plus conventional symptomatic supportive therapy (PAT). The SST group was given symptomatic supportive treatment, exercised on their own, and were observed at home after their symptoms improved. The PAT group was required to implement physical exercise along with SST, involving 30 min of moderate-intensity exercise per day and 5 days per week, and were discharged after 4 weeks and instructed to continue to exercise outside the hospital. Cancer-related fatigue (CRF) at 4 and 8 weeks was the primary endpoint of the study, while the secondary endpoints included patients' QOL, physical activity, and exercise adherence rate. Results: Sixty-five patients were included; 37 (56.92%) chose to enter the PAT group, and 28 (43.08%) chose to enter the SST group. After 4 and 8 weeks of treatment, CRF relief and QOL improvement were significantly better in the PAT group than in the SST group (p < 0.05), whereas global health status did not differ between the two treatment groups (T1: p = 0.84; T2: p = 0.92). Mild physical activity significantly increased for the PAT group at T1 and T2 (T1: p = 0.03; T2: p = 0.005). At the T2 time point, the PAT group exhibited a higher level of participation in moderate-intensity physical activities as well as a higher total leisure activity score (p < 0.05). Thirty-three patients (94.29%) completed the PAT exercise program during hospitalization. Only four (12.12%) patients achieved moderate-intensity exercise, while the other 29 (87.88%) patients were able to continue exercising after their exercise intensity was decreased. Conclusions: Implementation of precise and individualized exercise interventions, prescribed by the rehabilitation team, can lead to the reduction of CRF and improvement of QOL, and change in behavior related to physical activity.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A PHASE II RANDOMIZED STUDY OF NovoTTF THERAPY VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER PATIENTS WITH 1-5 BRAIN METASTASES FOLLOWING OPTIMAL STANDARD LOCAL TREATMENT
    Weinberg, Uri
    Kirson, Eilon
    Farber, Ori
    Palti, Yoram
    NEURO-ONCOLOGY, 2014, 16
  • [42] Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis
    Li, Jie
    Chen, Rong
    Ji, Mei
    Zou, Su-lan
    Zhu, Li-na
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 651 - 655
  • [43] Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis
    Jie Li
    Rong Chen
    Mei Ji
    Su-lan Zou
    Li-na Zhu
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 651 - 655
  • [44] Quality of Life of Cancer Patients under Adjuvant Mistletoe Treatment Results of a prospective, non-randomized, controlled, open study (post-marketing surveillance) with Iscador (R) M
    Toelg, Michael
    Antonu, Herbert
    Reiss, Bettina
    Ramos, Mac H.
    SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN, 2005, 17 (05): : 294 - 299
  • [45] Changes in Physical Activity, Physical Fitness and Well-Being Following a School-Based Health Promotion Program in a Norwegian Region with a Poor Public Health Profile: A Non-Randomized Controlled Study in Early Adolescents
    Schmidt, Sabrina K.
    Reinboth, Michael S.
    Resaland, Geir K.
    Bratland-Sanda, Solfrid
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (03)
  • [46] Home-Based Pulmonary Rehabilitation in Advanced Non-Small Cell Lung Cancer Patients Treated by Oral Targeted Therapy: A Feasibility Study
    Pagniez, Caroline
    Olivier, Cecile
    Olislagers, Alexandre
    Peres, Sophie
    Wasielewski, Eric
    Baranzelli, Anne
    Willemin, Marie-Capucine
    Dhalluin, Xavier
    Cortot, Alexis
    Hoorelbeke, Anne
    Scherpereel, Arnaud
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S690 - S690
  • [47] Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials
    Wang, Huiyu
    Zhang, Zunjing
    Liu, Feng
    Zhou, Miaoying
    Lv, Handi
    PTERIDINES, 2019, 30 (01) : 171 - 176
  • [48] A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment
    Janet Hardy
    Helen Skerman
    Paul Glare
    Jennifer Philip
    Peter Hudson
    Geoffrey Mitchell
    Peter Martin
    Odette Spruyt
    David Currow
    Patsy Yates
    BMC Cancer, 18
  • [49] A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment
    Hardy, Janet
    Skerman, Helen
    Glare, Paul
    Philip, Jennifer
    Hudson, Peter
    Mitchell, Geoffrey
    Martin, Peter
    Spruyt, Odette
    Currow, David
    Yates, Patsy
    BMC CANCER, 2018, 18
  • [50] Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial
    Yushu Zhou
    Baiming Zhao
    Wanyin Wu
    Xiaobing Yang
    Shunqin Long
    Hong Deng
    Wenfeng He
    Guiya Liao
    Qiuping Li
    Zhen Xie
    Trials, 19